8. Stock options and Warrants (Details Narrative) - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
|
| Share based compensation expense | $ 121,000 | $ 99,000 |
| Proceeds from warrant exercises | $ 61,000 | 172,000 |
| Stock price | $ 0.07 | |
| Warrants [Member] | ||
| Aggregate intrinsic value of warrants outstanding | $ 20,000 | |
| Warrants exercised | 1,155,000 | |
| Proceeds from warrant exercises | $ 58,000 | |
| Warrants [Member] | Consulting Agreement [Member] | ||
| Warrants granted | 99,999 | |
| Fair value of warrants granted | $ 7,000 | |
| Warrants [Member] | Convertible Notes [Member] | ||
| Warrants granted | 550,000 | |
| Options [Member] | ||
| Options granted | 2,699,998 | |
| Options exercised | 60,000 | |
| Fair value of options at grant date | $ 338,000 | |
| Share based compensation expense | 115,000 | $ 99,000 |
| Aggregate intrinsic value of options outstanding | 133,000 | |
| Unamortized compensation expense | $ 245,000 | |
| Weighted average life of options | 4 years 9 months 18 days | |
| Options [Member] | Board of Directors [Member] | ||
| Options exercised | 60,000 | |
| Option exercise price | $ 3,000 | |
| X | ||||||||||
- Definition Fair value of options at grant date No definition available.
|
| X | ||||||||||
- Definition Fair value of warrants granted No definition available.
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|